Near patient testing and pathology in the new millennium

Crook, Martin

doi:10.1136/jcp.53.1.27

Cited by 32 publications

(20 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On a direct-charging basis, decentralized testing and point-of-care testing are more expensive than central laboratory testing. [8][9][10][11] Point-of-care glucose testing, for example, is 3 to 4 times the cost of central laboratory glucose measurement. 11 In addition to cost concerns, the overuse of stat testing may create a situation in which a stat test is no longer handled in a significantly different fashion from a routine test.…”

Section: Participantsmentioning

confidence: 99%

“…[5][6][7] Thus, increased stat testing rates may increase costs relative to routine central laboratory testing. [8][9][10][11] The overuse of stat testing may also create a situation in which the stat test request is no longer handled in a significantly different fashion from a routine test. Underutilization of stat testing may hinder safe and efficient patient management.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Utilization of Stat Test Priority in the Clinical Laboratory: A College of American Pathologists Q-Probes Study of 52 Institutions

Volmar

Wilkinson

Wagar

et al. 2013

Archives of Pathology &Amp; Laboratory Medicine

View full text Add to dashboard Cite

Context.-Utilization of stat testing priority is a balance between safe, efficient patient management and resource expenditure.Objective.-To determine the rate of stat testing, compare rates among institutions, and determine the distribution of turnaround time expectations for different turnaround time priorities.Design.-During a 7-day period, participants prospectively determined the total number of chemistry, hematology, and coagulation billable tests from inpatients and emergency department patients. Among these, the total numbers of billable tests performed stat were identified. Laboratories also reported the levels of test priority they offered and turnaround expectations for each level of test priority.Results.-Fifty institutions submitted data for the study, with 2 additional participants submitting partial results.Participants identified 639 589 chemistry, hematology, and coagulation billable tests, with 229 896 (35.9%) performed stat. The stat rate varied from 21.3% at the 10th percentile to 55.4% at the 90th percentile, with a median of 37.0% of participants' tests performed stat. Laboratories include a mean of 206 tests in chemistry, hematology, and coagulation test menus, with 67% of these tests offered stat. The fraction of the test menu offered stat varied from 29.0% at the 10th percentile to 97.8% at the 90th percentile, with a median of 73.3% of tests on the menu offered stat. The most common number of testing priorities offered by participating laboratories was 3 (44.2%).Conclusions.-Among the 52 participating laboratories, the median stat testing rate was 37.0% and a median 73.3% of the test menu was offered stat.

show abstract

Section: Participantsmentioning

confidence: 99%

mentioning

confidence: 99%

Utilization of Stat Test Priority in the Clinical Laboratory: A College of American Pathologists Q-Probes Study of 52 Institutions

Volmar

Wilkinson

Wagar

et al. 2013

Archives of Pathology &Amp; Laboratory Medicine

View full text Add to dashboard Cite

show abstract

“…As point of care testing is likely to be done by staff with limited technical background, training and quality control are critical 2 3…”

Section: Organisation and Managementmentioning

confidence: 99%

Regular review: Point of care testing

Price

2001

BMJ

304

193

View full text Add to dashboard Cite

“…One of the most controversial aspects of POCT is the cost (7,8,10,11 ). In the intensive care unit, it may not be cost-effective to use POCT when a substantially less expensive central laboratory test is available.…”

mentioning

confidence: 99%

“…In many clinical settings, POCT has been reported to improve patient care (7)(8)(9)(10)(11)(12). One of the most controversial aspects of POCT is the cost (7,8,10,11 ).…”

mentioning

confidence: 99%